Fingerprint
Dive into the research topics of 'Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically